Takeda Pharmaceutical Company Limited, et al. v. Actavis Laboratories FL, Inc., C.A. No. 15-451-RGA, June 6, 2016.
Andrews, J. Claim construction opinion issues regarding three terms from two patents. A Markman hearing took place on May 24, 2016.
The disputed technology relates to medication for weight loss management. The following terms were considered:
- “a weight loss effective amount of a first and second compound”
- “having reduced adverse effects”